Swartz Robin's most recent trade in Voyager Therapeutics Inc was a trade of 142,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 142,500 | 142,500 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 71,250 | 169,647 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Sale of securities on an exchange or to another person at price $ 4.25 per share. | 20 Feb 2025 | 3,894 | 98,397 (0%) | 0% | 4.3 | 16,550 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 11 Feb 2025 | 6,950 | 102,291 (0%) | 0% | 4.5 | 30,928 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 14 Jan 2025 | 3,087 | 109,241 (0%) | 0% | 5.1 | 15,713 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | COO&CBO | Sale of securities on an exchange or to another person at price $ 5.65 per share. | 23 Dec 2024 | 6,500 | 112,328 (0%) | 0% | 5.7 | 36,725 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.88 per share. | 02 Apr 2024 | 1,357 | 117,004 (0%) | 0% | 9.9 | 13,407 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.45 per share. | 21 Feb 2024 | 3,966 | 118,361 (0%) | 0% | 7.5 | 29,547 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Swartz Robin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 50,000 | 122,327 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Swartz Robin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.15 per share. | 17 Jan 2024 | 2,543 | 72,327 (0%) | 0% | 7.1 | 18,182 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.83 per share. | 03 Apr 2023 | 1,259 | 71,617 (0%) | 0% | 7.8 | 9,858 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 20 Mar 2023 | 3,654 | 72,876 (0%) | 0% | 7.8 | 28,355 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.20 per share. | 15 Mar 2023 | 15,373 | 76,530 (0%) | 0% | 8.2 | 126,059 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 40,000 | 91,903 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 17 Jan 2023 | 1,396 | 52,695 (0%) | 0% | 9.6 | 13,360 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 17 Jan 2023 | 792 | 51,903 (0%) | 0% | 10.3 | 8,189 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 04 Apr 2022 | 1,527 | 52,060 (0%) | 0% | 8.3 | 12,598 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.29 per share. | 21 Mar 2022 | 4,362 | 53,638 (0%) | 0% | 8.3 | 36,161 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.69 per share. | 21 Mar 2022 | 51 | 53,587 (0%) | 0% | 8.7 | 443 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) |